Skip to search.
 BSE Up0.19% NSE Up0.28%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.04 Up 0.04(0.50%) 18 May 1:30AM|After Hours : 8.01 Down 0.03 (0.37%) 18 May 2:14AM

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.6
Mean Recommendation (last week):1.5
Change:0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:12.44
Median Target:13.00
High Target:15.00
Low Target:8.00
No. of Brokers:9

Data provided by Thomson/First Call
Upgrades & Downgrades History
DateResearch FirmActionFromTo
13-Dec-2012Maxim GroupInitiated Buy
13-Nov-2012Burrill Institutional ResearchInitiated Mkt Outperform
10-May-2012Ladenburg ThalmannUpgradeNeutralBuy
03-Apr-2012Ladenburg ThalmannDowngradeBuyNeutral
17-May-2011OppenheimerInitiated Outperform
06-May-2011MLV CapitalInitiated Buy
16-Mar-2011JMP SecuritiesInitiated Mkt Outperform
01-Mar-2010Rodman & RenshawInitiated Mkt Outperform
25-Feb-2010Roth CapitalInitiated Buy
11-Mar-2008Banc of America SecDowngradeBuyNeutral
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0444
Buy0444
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.